Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor Cell Lymphoblastic Leukemia-Lymphoma × Pemetrexed × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 56 Lung Neoplasms 28 Neoplasm Metastasis 8 Neoplasms 7 Colorectal Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Carcinoma 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Mesothelioma, Malignant 3 Colonic Neoplasms 3 Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Pancreatic Neoplasms 2 Non-Squamous Non-small Cell Lung Cancer 2 Neoplasms by Site 2 Lung Diseases 2 Carcinoma, Pancreatic Ductal 2 Carcinoma, Bronchogenic 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumor, Pleural 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Recurrence 1 Pathologic Processes 1 Pathologic Complete Response 1

Interventions

Cyclophosphamide 22 fludarabine 15 Vincristine 12 fludarabine phosphate 11 Methotrexate 10 Granulocyte Colony-Stimulating Factor 9 Filgrastim 9 venetoclax 8 blinatumomab 8 Melphalan 8 Dexamethasone 8 Cytarabine 8 Whole-Body Irradiation 7 Stem Cell Transplantation 6 Rituximab 6 Mycophenolic Acid 6 Magnetic Resonance Spectroscopy 6 Calcium Dobesilate 6 ponatinib 5 merphos 5 dexamethasone acetate 5 dexamethasone 21-phosphate 5 Thiotepa 5 Tacrolimus 5 Mesna 5 Etoposide 5 Doxorubicin 5 Busulfan 5 calaspargase pegol 4 auricularum 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡